Clinical trial · Interventional
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
Advancing Cervical Cancer Screening Through the Emergency Department
NCT06796738CI-TRIAL-00101044active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cervical cancer screening in the Emergency Department
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancers | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| HPV | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV testing | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Intervention Arm - testing
- description
- Participants in this arm will be provided the opportunity to self- sample for HPV during their ED visit. Participants will be (1) briefly instructed by the study staff on how to self-sample using a defined instructional script written at an elementary reading level, (2) provided with a packaged swab and vial of transport media, and (3) invited to self- sample privately in their ED room or in one of the private ED restrooms.
- interventionNames
- Diagnostic Test: HPV testing
Primary outcomes (1)
- measure
- Uptake of Cervical Cancer Screening
- timeFrame
- 150 days post initial intervention
- description
- All intervention participants will receive a follow-up call at 150 days to assess uptake of any cervical cancer screening and for completion of the cervical cancer screening process. "Any cervical cancer screening" is defined as uptake of any aspect of the cervical cancer screening process, including self-sampling and/or clinic-based screening. "Completion of the cervical cancer screening process" is defined as completion of recommended clinic-based screening (including colposcopy if HPV 16/18+ or indicated).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Cisgender women and transgender/non-binary individuals with a cervix, * Age 25-65, * Able to demonstrate decisional capacity to participate. Exclusion Criteria: * Past hysterectomy with cervical removal, * Known infection with HIV (as screening recommendations for people with HIV differ from the general population), * Non-English speaking.
References
Publications (0)
Data not yet available
No reference posted for this study.